Bajpayee, D. P. (1975) . Annals ofthe Rheumatic Diseases, 34, 162. Signific of plasma copper and caeruloplmin concentrations in rheumatoid arthritis. To understand the role of copper in initiating protein alterations in rheumatoid arthritis (RA) as reported previously, concentrations ofcopper and caeruloplasmin were determined in RA patients. The mean copper concentration of the RA population examined was 24 8 1umol/l (157 5 ,ug/100 ml), and the mean caeruloplasmin concentration in this RA population was 45 52 mg/100 ml. These values are not different from those reported by previous workers. However, when the RA population was divided into three groups according to sex and oestrogen therapy it was found that caeruloplasmin and copper concentrations in the group of female RA patients on oestrogens was significantly different from other groups (P < 0-001). A highly significant (P < 0 01) positive correlation was obtained between copper and caeruloplasmin concentrations (r = 0 91).
Concentrations ofcopper and caeruloplasmin failed to explain the low sulphydryl content of plasma which was observed to be independent of these two parameters. Increased a2-globulin concentration, which was refractory to chrysotherapy but 'finger-printed' with a pure preparation of caeruloplasmin in electrophoresis, along with the absence of Kayser-Fleischer rings, supports the contention that copper is not present in a free ionic state in RA patients. This study shows that only a concurrent oestrogen therapy raises copper and caeruloplasmin concentration significantly in a female RA population. Past investigators appear to have overlooked this fact, and it could be that a disproportionate sex distribution (more female rheumatoid arthritics) could cause misleading results in RA studies. The role of oestrogens, copper, and caeruloplasmin in causing exacerbation of RA symptoms is discussed.
This investigation was designed to study plasma copper and caeruloplasmin concentration in rheumatoid arthritis (RA) (Carruthers, Hobbs, and Warren, 1966) and considering the growing contention that oestrogens are implicated in inducing rheumatic symptoms (Kay and Bole, 1971) , it was felt that dividing the RA population by sex and oestrogen therapy was essential for rational interpretation of copper and caeruloplasmin concentration data and their relationship to disease activity in RA. The effect of the rise in these two parameters on plasma sulphydryl group content has been of further interest and was undertaken to resolve some questions and extend some observations of previous studies carried out by Lorber and co-workers (Lorber, Cutler, and Chang, 1968; Lorber and others, 1964) .
Materials and methods

COLLECTION OF BLOOD SPECIMENS
Blood was collected into heparinized containers from patients who had a diagnosis of definite or classical RA, and normal healthy volunteers of both sexes. The tubes were centrifuged at 2000 r.p.m. to obtain plasma. Plasma was either analysed fresh or was frozen at -20°C till analysed.
ANALYSIS OF COPPER
Copper was determined in plasma samples by atomic absorption spectrometry using internal standards. The method followed was that described by Lorber and others (1968) except that the standard solution used in this laboratory is a cocktail containing copper and gold at a concentration of 78i7 ,mol/l (500 pg/100 ml) and 25-4 pumol/l (500 jug/100 ml), respectively. This mixed standard enables us to utilize the same plasma sample for both copper and gold determinations (for patients on chrysotherapy) by switching to hollow cathode ray tube of the particular metal to be analysed in the sample. All analyses were carried out on Model Dial-Atom atomic absorption spectrometer (Jarrel Ash Division, Fisher Scientific Co.) at 321 wavelength.
SULPHYDRYL GROUP ANALYSIS
Sulphydryl groups were determined in plasma samples by the spectrophotometric method of Ellman (1958) . The plasma samples of twenty healthy, normal individuals of both sexes analysed for sulphydryl groups by this method gave a range of 448-734 pumol/l with a mean value of 591 pmol/l.
DETERMINATION OF CAERULOPLASMIN
Caeruloplasmin was determined in plasma samples by the method outlined by Henry and co-workers (Henry, Chiamori, Jacobs, and Segalove, 1960) . Plasma samples with high caeruloplasmin concentration were diluted 1:1 with normal saline before enzyme assay.
STATISTICAL ANALYSIS
Correlation coefficient and linear regression analyses were carried out as described by Li (1961) (1965) that caeruloplasmin accounts for essentially the total increase in copper in RA serum. Fig. 2 compares serial studies on two female patients undergoing chrysotherapy, and shows clearly that the patient on oral contraceptive consistently maintained a high copper and caeruloplasmin level with raised a2-globulin. However, the copper and caeruloplasmin content remained normal and the a2-globulin dropped under the influence ofchrysotherapy in the patient not taking any oestrogens. The a2-globulin present in the patient taking oral contraceptive migrated and 'fingerprinted' exactly with a pure commercial caeruloplasmin preparation (Sigma Chemical Co., St. Louis, Mo.) on electrophoresis. These findings are similar to those reported by Beam and Kunkel (1954) , Gubler, Lahey, Brown, Smith, Cartwright, and Wintrobe (1951) , and Scheinberg and Morell (1957) .
Discussion
Numerous reports have established the role of both endogenous and exogenous oestrogens in raising the concentration of serum copper and caeruloplasmin (O' Leary and Spellacy, 1969; O'Leary, 1969; O'Leary and Feldman, 1968; Carruthers and others, 1966) in normal females. Oestrogens also produce hypergammaglobulinaemia, increase the number of plasma cells, and produce stromal hypertrophy of spleen in NZB/NZW mice (Walker and Bole, 1971 ). Oral contraceptives have been shown to initiate antinuclear antibody production, raise the rheumatoid factor titre, and produce a positive LE cell test (Kay and Bole, 1971) . Past evidence (Nicol, Vernon-Roberts, and Quantock, 1966a, b; Nicol, Bilbey, Charles, Cordingley, and Vernon-Roberts, 1964) suggests that oestrogens are also highly potent in stimulating the reticuloendothelial system (RES) and in raising body defense. These serological abnormalities induced by oestrogens in RA patients cannot explain the raised levels of copper and caeruloplasmin which are also found in normal (Cumings, 1971) .
Our study fails to confirm the report of Lorber and others (1968) that an error is involved in copper metabolism in RA. However, it shows the specificity of oestrogens in raising caeruloplasmin levels in female RA patients. Fig. 3 
